Cigna Corporation (CI) Shares Sold by Dodge & Cox
Dodge & Cox decreased its position in Cigna Corporation (NYSE:CI) by 3.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,909,629 shares of the health services provider’s stock after selling 489,949 shares during the period. Cigna Corporation makes up 2.0% of Dodge & Cox’s portfolio, making the stock its 19th largest position. Dodge & Cox owned approximately 5.43% of Cigna Corporation worth $2,328,333,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Guardian Life Insurance Co. of America grew its holdings in shares of Cigna Corporation by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares during the period. Pacer Advisors Inc. boosted its stake in Cigna Corporation by 3.0% in the 2nd quarter. Pacer Advisors Inc. now owns 5,581 shares of the health services provider’s stock worth $934,000 after purchasing an additional 165 shares during the period. Lockheed Martin Investment Management Co. acquired a new position in Cigna Corporation in the 2nd quarter worth $670,000. Swiss National Bank boosted its stake in Cigna Corporation by 3.0% in the 2nd quarter. Swiss National Bank now owns 1,006,174 shares of the health services provider’s stock worth $168,423,000 after purchasing an additional 29,700 shares during the period. Finally, Schroder Investment Management Group boosted its stake in Cigna Corporation by 1,794.4% in the 2nd quarter. Schroder Investment Management Group now owns 187,770 shares of the health services provider’s stock worth $31,301,000 after purchasing an additional 177,858 shares during the period. 87.94% of the stock is owned by institutional investors.
In related news, Chairman Isaiah Harris, Jr. sold 247 shares of the business’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director William D. Zollars sold 1,232 shares of Cigna Corporation stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 70,653 shares of company stock worth $12,437,684. 1.30% of the stock is owned by corporate insiders.
A number of equities analysts recently weighed in on the stock. UBS AG reaffirmed a “buy” rating and issued a $193.00 target price (up from $186.00) on shares of Cigna Corporation in a research note on Thursday, June 22nd. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $185.00 target price on shares of Cigna Corporation in a research note on Wednesday, August 9th. Deutsche Bank AG upped their target price on shares of Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Zacks Investment Research lowered shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $191.00 target price on shares of Cigna Corporation in a research note on Sunday, September 17th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. Cigna Corporation currently has an average rating of “Buy” and an average target price of $182.59.
Shares of Cigna Corporation (CI) traded down 0.78% during midday trading on Friday, hitting $180.71. 423,217 shares of the stock were exchanged. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36. The stock has a market capitalization of $45.50 billion, a price-to-earnings ratio of 20.85 and a beta of 0.43. The firm’s 50 day moving average is $180.07 and its 200-day moving average is $165.77.
Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. During the same period in the previous year, the company earned $1.98 earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, analysts predict that Cigna Corporation will post $10.02 EPS for the current year.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.